[Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase].
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D004298:Dopamine / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D007421:Intestine, Small / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008624:Mercaptoethylamines / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D000338:beta-Aminoethyl Isothiourea / Q000494:pharmacology
D008624:Mercaptoethylamines; D011837:Radiation-Protective Agents; D000338:beta-Aminoethyl Isothiourea; D012701:Serotonin; D006632:Histamine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases; D004298:Dopamine
Deĭstvie radioprofilakticheskikh preparatov na uroven' tsiklicheskogo adenozin-3',5'-monofosfata (tsAMF), aktivnost' adenilattsiklazy i fosfodiésterazy tsAMF